ResearchMultiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies
ResearchCharacterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics
ResearchExceptional Response to Pembrolizumab and Trastuzumab in a Heavily Pretreated Patient With HER2-Positive TMB-H and MSI-H Metastatic Breast Cancer
ResearchClinical trial design: Past, present, and future in the context of big data and precision medicine